Rchr
J-GLOBAL ID:201901001250845016   Update date: Jun. 23, 2021

Hideki Yoshida

ヨシダ ヒデキ | Hideki Yoshida
Affiliation and department:
Job title: 助教
Research field  (5): Fetal medicine/Pediatrics ,  Tumor diagnostics and therapeutics ,  Tumor biology ,  Tumor biology ,  Tumor diagnostics and therapeutics
Research keywords  (5): 細胞療法 ,  Virotherapy ,  Oncology ,  Hematology ,  Pediatrics
Research theme for competitive and other funds  (8):
  • 2020 - 2023 CD19発現型AdVとCD19 CAR-T細胞を組み合わせた遺伝子細胞治療戦略 英文
  • 2020 - 2022 Rhabdoid tumorに対する新規腫瘍溶解性アデノウイルス製剤の開発
  • 2019 - 2021 Development of oncolytic adenovirus with costimulatory factor, contributing to suppress CAR-T cell exhaustion
  • 2018 - 2020 MYOG Promoter-Controlled Oncolytic Adenovirus to Treat PAX3-FOXO1- Positive Rhabdomyosarcoma
  • 2015 - 2017 Development of the new treatment for ETP-ALL
Show all
Papers (24):
more...
MISC (11):
more...
Lectures and oral presentations  (17):
  • MYOG promoter-controlled oncolytic adenovirus with MEF2 mutation kills PAX3-FOXO1 positive rhabdomyosarcoma cells selectively
    (61st Annual Meeting of the Japanese Society of Pediatric Hematology / Oncology 2019)
  • AdMG-MYOGp-E1-5/3F, MYOG promoter controlled oncolytic adenovirus, kills rhabdomyosarcoma cells selectively in vivo
    (51st Congress of the International Society of Paediatric Oncology 2019)
  • GD2 significantly promotes tumor incidence due to inducing angiogenesis in SH4 melanoma cell line
    (78th Annual Meeting of the Japanese Cancer Association 2019)
  • MYOG promoter-controlled oncolytic adenovirus, AdMG-MYOGp(S)-E1-5/3F, kills rhabdomyosarcoma cells selectively
    (25th Annual Meeting of Japan Society of Gene and Cell Therapy 2019)
  • AdMG-MYOGp(S)-E1-5/3F, MYOG promoter-controlled oncolytic adenovirus, selectively kills rhabdomyosarcoma cells
    (22nd Annual Meeting of American Society of Gene & Cell Therapy 2019)
more...
Education (2):
  • 2012 - 2016 Kyoto Prefectural University of Medicine Department of Pediatrics
  • 1998 - 2004 Kyoto Prefectural University of Medicine Department of Medicine
Professional career (2):
  • MD (Kyoto prefectural university of medicine)
  • PhD (Kyoto prefectural university of medicine)
Work history (8):
  • 2020/04 - 現在 Kyoto Prefectural University of Medicine Department of Pediatrics Assistant Professor
  • 2019/04 - 2020/03 Kyoto Prefectural University of Medicine Professional Training Center in Cancer Medicine Assistant Professor
  • 2016/04 - 2019/03 University of Minnesota Division of Basic and Translational Research, Department of Surgery Postdoctoral associate
  • 2012/04 - 2016/03 North Medical Center, Kyoto Prefectural University of Medicine Department of Pediatrics Assistant head physician
  • 2008/04 - 2012/03 Kyoto Prefectural University of Medicine Department of Pediatrics, Graduated school of Medical Science Graduated student
Show all
Awards (4):
  • 2019/05 - American Society of Gene & Cell Therapy Travel Award, 22st Annual Meeting of ASGCT AdMG-MYOGp(S)-E1-5/3F, MYOG promoter-controlled oncolytic adenovirus, selectively kills rhabdomyosarcoma cells
  • 2014/11 - Japanese Society of Pediatric Hematology / Oncology Best Poster Award, 56th Congress of JPHO Analysis of the risk factors for hyperglycemia related to L-asparaginase in the patients with ALL registered
  • 2014/03 - Kyoto Prefectural University of Medicine 24th Best Paper Award, an alumni association in Kyoto Prefectural University of Medicine PAX3-NCOA2 fusion gene has a dual role in promoting the proliferation and inhibiting the myogenic differentiation of rhabdomyosarcoma cells
  • 2011/10 - International Society of Paediatric Onocology Best Poster Award, 43rd Congress of SIOP PAX3-NCOA2 plays a dual role in tumorigenesis of embryonal rhabdomyosarcoma
Association Membership(s) (11):
The Japan Society of Transfusion Medicine and Cell Therapy ,  INTERNATIONAL SOCIETY OF PAEDIATRIC ONCOLOGY ,  AMERICAN SOCIETY OF GENE AND CELL THERAPY ,  AMERICAN SOCIETY OF HEMATOLOGY ,  JAPANESE SOCIETY FOR PALLIATIVE MEDICINE ,  JAPAN SOCIETY OF GENE AND CELL THERAPY ,  THE JAPANESE CANCER ASSOCIATION ,  THE JAPAN SOCIETY FOR HEMATOPOIETIC CELL TRANSPLANTATION ,  THE JAPANESE SOCIETY OF PEDIATRIC HEMATOLOGY/ONCOLOGY ,  THE JAPANESE SOCIETY OF HEMATOLOGY ,  JAPAN PEDIATRIC SOCIETY
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page